Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Fang Shu-Hua ESPP Purchase of 58 TSM Shares at $70.50

Taiwan Semiconductor Manufacturing Co Ltd SVP and General Counsel Fang Shu-Hua filed a Form 4 on November 10, 2026, disclosing a purchase of 58 common shares on November 6, 2026, through the company's Employee Stock Purchase Plan.

Aakashdeep | 10 November 2026

TSMC CFO Huang Jen-Chau Buys 30 Shares via ESPP on Nov 6

Taiwan Semiconductor Manufacturing Co Ltd SVP and CFO Huang Jen-Chau filed a Form 4 on November 10, 2026, disclosing a purchase of 30 common shares on November 6, 2026, through the company's Employee Stock Purchase Plan.

Manish Choudhary | 10 November 2026

Chuang Tzu-Sou ESPP Purchase: 48 TSM Shares at $70.50

Taiwan Semiconductor Manufacturing Co Ltd Vice President Chuang Tzu-Sou filed a Form 4 on November 10, 2026, disclosing a purchase of 48 common shares on November 6, 2026, through the company's Employee Stock Purchase Plan.

Manish Choudhary | 10 November 2026

Why Powerfleet (NASDAQ:AIOT) Climbed on the Russell 2000: It Posted Record Quarterly Revenue

● The company maintained its fiscal 2027 forecast.

Nitish Kishor | 10 November 2026

Why AAR Corp. (NYSE:AIR) Climbed on the NYSE Composite: It Rose on China's Rare-Earth Relief

● It rose with other industrial and aerospace names.

Nitish Kishor | 10 November 2026

Why Amwell (NYSE:AMWL) Climbed on the NYSE Composite: It Beat Its Revenue Guidance and Raised Its Outlook

● The 2026 revenue outlook rose to $204 million to $206 million.

Nitish Kishor | 10 November 2026

Why Digital Turbine (NASDAQ:APPS) Tumbled After the Bell on the Nasdaq Composite: Its EBITDA Outlook Trailed Estimates

Key Highlights● Digital Turbine tumbled after hours on November 9.● The drop was roughly a fifth of the stock's value.● Revenue beat expectations.● The reiterated EBITDA range had a midpoint below estimates.A beat that did not satisfyDigital Turbine (NASDAQ:APPS) tumbled in after-hours trading on …

Nitish Kishor | 10 November 2026

Why Arrowhead Pharmaceuticals (NASDAQ:ARWR) Tumbled on the Nasdaq Composite with No Company-Specific News Found

● The decline came on one of the strongest market days in months.

Nitish Kishor | 10 November 2026
Support

Hi! How can we help you today?

Loading…